UNSPSC 51161555: Seratrodast

This classification denotes an anti-asthmatic agent with the molecular formula C22H26O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U58JM421N, chemically known as benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)- but generally known as seratrodast, which bears US NIH Compound Identifier 2449. European Medicines Agency schedules Seratrodast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10490MIG.

UNSPSC 51161555 Seratrodast is a Commodity code covering a specific pharmaceutical active ingredient used in respiratory and allergy treatment formulations. State and local governments procure seratrodast primarily through health departments, correctional facilities, and public hospital systems as part of formulary acquisitions and emergency medication stockpiling. The procurements are typically small-volume, specialized purchases tied to inmate health programs, public clinic operations, or strategic pharmaceutical reserves rather than large-scale manufacturing or distribution contracts. Issuing bodies are predominantly state health and corrections departments, with occasional participation from county health systems and municipal hospital authorities.

The source provides no recent state and local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB records naming seratrodast acquisitions, current market activity and geographic concentration cannot be characterized. The code may see activity through closed cooperative purchasing agreements, sole-source acquisitions exempt from competitive notice, or bulk formulary contracts negotiated outside the public solicitation cycle — patterns common in pharmaceutical procurement at the state and local level.